Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA GLENMARK PHARMA BAL PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 40.8 -31.4 - View Chart
P/BV x 2.3 2.9 79.1% View Chart
Dividend Yield % 1.1 0.3 419.9%  

Financials

 BAL PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
BAL PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs134487 27.5%   
Low Rs63349 18.2%   
Sales per share (Unadj.) Rs193.9460.4 42.1%  
Earnings per share (Unadj.) Rs1.713.4 12.5%  
Cash flow per share (Unadj.) Rs7.535.0 21.4%  
Dividends per share (Unadj.) Rs1.002.50 40.0%  
Avg Dividend yield %1.00.6 169.3%  
Book value per share (Unadj.) Rs40.7335.1 12.1%  
Shares outstanding (eoy) m15.69282.17 5.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.50.9 56.1%   
Avg P/E ratio x59.231.3 189.3%  
P/CF ratio (eoy) x13.211.9 110.5%  
Price / Book Value ratio x2.41.2 194.7%  
Dividend payout %59.918.7 320.5%   
Avg Mkt Cap Rs m1,549117,953 1.3%   
No. of employees `000NANA-   
Total wages/salary Rs m55327,810 2.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,042129,901 2.3%  
Other income Rs m93,168 0.3%   
Total revenues Rs m3,052133,069 2.3%   
Gross profit Rs m25315,125 1.7%  
Depreciation Rs m916,113 1.5%   
Interest Rs m1233,496 3.5%   
Profit before tax Rs m478,685 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m214,911 0.4%   
Profit after tax Rs m263,774 0.7%  
Gross profit margin %8.311.6 71.3%  
Effective tax rate %44.856.5 79.3%   
Net profit margin %0.92.9 29.6%  
BALANCE SHEET DATA
Current assets Rs m2,28298,737 2.3%   
Current liabilities Rs m2,09350,455 4.1%   
Net working cap to sales %6.237.2 16.6%  
Current ratio x1.12.0 55.7%  
Inventory Days Days87 114.4%  
Debtors Days Days1,128115 979.1%  
Net fixed assets Rs m82976,920 1.1%   
Share capital Rs m157282 55.6%   
"Free" reserves Rs m48194,281 0.5%   
Net worth Rs m63894,563 0.7%   
Long term debt Rs m30538,521 0.8%   
Total assets Rs m3,110175,658 1.8%  
Interest coverage x1.43.5 39.8%   
Debt to equity ratio x0.50.4 117.5%  
Sales to assets ratio x1.00.7 132.3%   
Return on assets %4.84.1 116.0%  
Return on equity %4.14.0 102.9%  
Return on capital %18.19.2 197.7%  
Exports to sales %66.40-   
Imports to sales %22.40-   
Exports (fob) Rs m2,020NA-   
Imports (cif) Rs m683NA-   
Fx inflow Rs m2,02046,464 4.3%   
Fx outflow Rs m71612,712 5.6%   
Net fx Rs m1,30533,751 3.9%   
CASH FLOW
From Operations Rs m-186,254 -0.3%  
From Investments Rs m-222-5,285 4.2%  
From Financial Activity Rs m244-775 -31.5%  
Net Cashflow Rs m4325 1.2%  

Share Holding

Indian Promoters % 47.1 46.7 100.9%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 0.1 34.7 0.4%  
FIIs % 0.1 23.7 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 53.4 91.4%  
Shareholders   15,060 209,931 7.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs Glenmark Pharma Share Price Performance

Period BAL PHARMA Glenmark Pharma S&P BSE HEALTHCARE
1-Day -4.61% -0.76% 1.28%
1-Month -17.94% 4.96% -0.65%
1-Year 40.62% 112.54% 61.98%
3-Year CAGR 18.95% 27.43% 18.20%
5-Year CAGR 5.38% 8.01% 19.81%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.